Access to Medicines in the Developing World

Our aim is to provide universal access to our medicines, particularly for low- and middle-income countries in the developing world. We rely on a number of company-wide policies, programs and innovative initiatives to guide our efforts.

Commitment to Patients

We work hard to develop treatments to address unmet medical needs and then work even harder to enhance access. We’ve developed specific policies to help guide our efforts for universal access to our medicines.

Access Management

Here are specific programs and partnerships to help facilitate and manage access to our medicines.

Research and Development

Our R&D efforts address important unmet medical needs across a number of disease and therapeutic areas.

Partnering with Patients and Physicians

Patient assistance and support programs take various forms in different countries around the world. See how we work locally to help patients get the medicines they need.

Clinical Trials

We enable health care institutions in other countries to strengthen their own clinical trial capabilities.

Improving Health Care Infrastructure and Practices

By improving local health care infrastructure, we support an environment where patients can get the most innovative treatments.

Patents, Licensing, and Technology Transfer

We are committed to ensuring that patents do not prevent access to therapy in resource-constrained countries.

Product Quality and Safety

We are committed to providing the highest quality products and ensuring product integrity throughout the product lifecycle.

Drug Donations and Philanthropic Efforts

We support philanthropic efforts to promote health equity and improve the health outcomes of populations disproportionately affected by serious diseases and conditions.

HCV Developing World Strategy

We believe in a coalition approach to enable global access to HCV treatment in the developing world.